AnaBios

AnaBios aims to establish the safety and efficacy of novel compounds through its advanced, human-focused translational technologies, including superior quality human tissue samples and functional assays focused, as well as human primary cells through its subsidiary Cell Systems.

MEPSGEN

Advanced microfluidic technologies for Nanomedicine Development. We develop and employ human microphysiological systems or organ-on-a-chip to better predict drug toxicity and efficacy.

Ncardia

For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC).

Ananda Devices

Ananda Devices is a biotech company offering high throughput organ on-a-chip technologies such as neurons on-a-chip to accelerate R&D in pharmaceutical, food and cosmetic (PFC) industries

StemPharm

Stem Pharm offers functional 2-D and 3-D human tissue models for disease modeling, drug discovery, and toxicity screening. We specialize in neural organoid and vascular models. Our team of scientists can also help users identify and develop unique synthetic hydrogels for their own MPS needs.

Emulate

Emulate develops a breadth of Organ-Chip models with a focus on recreating the microenvironment and mechanical forces cells experience in vivo. Hardware automating media flow and stretch, Bio-Kits including chips and qualified human cells, and a range of standard and custom services are available.

Hesperos Inc.

Hesperos is accelerating drug discovery by providing safety and efficacy testing services using its Human-on-a-Chip, microphysiological system. This breakthrough technology enables unprecedented preclinical insight bringing better therapies to patients faster without the need for animal testing.

CN Bio

CN Bio is a leading bioengineering company specializing in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines.